Overview

Study of Participants With Advanced Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2020-11-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the regimens of pemetrexed, carboplatin with pemetrexed maintenance and paclitaxel, carboplatin, bevacizumab with bevacizumab maintenance in participants with Stage IV nonsquamous non-small cell lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Albumin-Bound Paclitaxel
Bevacizumab
Carboplatin
Paclitaxel
Pemetrexed